EU tests effect of ‘Remdesivir’ on kidneys

Source : 112 Ukraine

Some patients were found to have impaired renal function after taking Remdesivir
12:34, 3 October 2020

Covid-19 drug remdesivir

The European Union began testing the effect of Remdesivir on the kidneys after some patients were found to have kidney problems. Deutsche Welle reports.

Remdesivir reportedly caused acute kidney disease in some patients. It is not yet known if they were caused by the coronavirus or the drug itself.

Related: Covid-19 sends Trump to military hospital in Maryland

As you know, US President Donald Trump, who was also diagnosed with coronavirus, began to take this drug.

As a reminder, Remdesivir was developed by a Californian biopharmaceutical company to combat Ebola. In mid-April 2020, Canadian scientists reported that the drug prevents the coronavirus from multiplying.

As we reported before, in Jerusalem's Hadassah Ein Kerem hospital, an experiment was conducted to treat patients with COVID-19 using biological cells taken from healthy people.

"On the eve of September 30, a fifth of five critically ill patients were discharged after receiving innovative treatment in the first clinical trial of this kind," the report said.

Related: Ukrainian Foreign Ministry still sees no reason to sever diplomatic relations with Belarus

Система Orphus

If you find an error, highlight the desired text and press Ctrl + Enter, to tell about it

see more